4//SEC Filing
EAGLE PHARMACEUTICALS, INC. 4
Accession 0001209191-17-022324
CIK 0000827871operating
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:47 PM ET
Size
5.2 KB
Accession
0001209191-17-022324
Insider Transaction Report
Form 4
Edlin Richard A.
Director
Transactions
- Purchase
Common Stock
2017-03-22$79.44/sh+6,000$476,640→ 29,400 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $79.19 to $79.68, inclusive. The reporting person undertakes to provide to Eagle Pharmaceuticals, Inc., any security holder of Eagle Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000827871
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:47 PM ET
- Size
- 5.2 KB